Genmab — Oktober 2017
-
har det ikke mest (historisk), at det har været kassebeholdningen, der blev dækket af?
-
hvis vi havner i 360-370 lejet i dag, så vil det i hvert fald ikke være seriøst at holde fast i 1100-1300 intervallet længere. Gad vide om vi kan få en guidance præcisering i dag?
-
alt er dollars, det går jo via J&J
-
MarketWatch skriver at orkanerne i september kan have indflydelse på både efterspørgsel på og udbud af medicin. http://www.marketwatch.com/story/johnson-johnson-earnings-all-eyes-on-hurricane-impact-2017-10-16?siteid=yhoof2&yptr=yahoo
-
JNJ Webcasts 14.30 via
http://www.investor.jnj.com/events.cfm -
Øjs - nogen må have røde ører. Kan det påvirke Genmab positivt ? http://medwatch.dk/Medicinal___Biotek/article9955845.ece?utm_campaign=Middag&utm_content=2017-10-17 12%3A15%3A52&utm_medium=top&utm_source=Feed
-
Er det kl. 13 regnskabet lander fra J&J?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind